TOKYO, June 25, 2026 (GLOBE NEWSWIRE) -- MEDIROM MOTHER Labs Inc. (Headquarters: Minato-ku, Tokyo; President: Yoshio Uekusa), a subsidiary of MEDIROM Healthcare Technologies Inc. ((Headquarters: Minato-ku, Tokyo,
TOKYO, May 28, 2026 (GLOBE NEWSWIRE) -- This report presents an overview of our business performance and key performance indicators (KPIs) for the first quarter of 2026 (January–March 2026). It also highlights trends
TOKYO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. ((Headquarters: Minato-ku, Tokyo, President and CEO: Kouji Eguchi, NASDAQ:MRM) announced that the Master Service Agreement (the "Agreement")
TOKYO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo, President and CEO: Kouji Eguchi, NASDAQ:NASDAQ, hereinafter "MEDIROM"), a company engaged in diversified
TOKYO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM, MEDIROM or the "Company"), announces that the cumulative number of Proof
TOKYO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM, MEDIROM or the "Company"), a diversified healthcare company, collaborating
TOKYO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM, MEDIROM or the "Company"), a diversified healthcare company, is
TOKYO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("MEDIROM") today announced that its subsidiary, MEDIROM MOTHER Labs Inc. ("MOTHER Labs"), which develops health-tech
TOKYO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc., (Headquarters: Minato-ku, Tokyo, President and CEO: Kouji Eguchi, NASDAQ:MRM, hereinafter "the Company") hereby announces the launch of a
TOKYO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. ((Headquarters: Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM), today announced that as of October 23, 2025, the Company surpassed 10,000
TOKYO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- MEDIROM MOTHER Labs Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Yoshio Uekusa; hereinafter "MOTHER Labs"), a subsidiary of MEDIROM Healthcare Technologies Inc.
TOKYO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. ((Headquarters: Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM), a diversified healthcare company, has joined "World," a "proof of
TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("MEDIROM") today announced that its subsidiary, MEDIROM MOTHER Labs Inc. ("MOTHER Labs"), has begun providing its remote
TOKYO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("MEDIROM", "we" or "us") announces that its "REMONY for Driver" remote health management system, developed by its subsidiary